Patents by Inventor Ray Takigiku

Ray Takigiku has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230330180
    Abstract: Disclosed are compositions containing a saposin C polypeptide and a phospholipid and methods that are useful for treating viral infections.
    Type: Application
    Filed: January 9, 2023
    Publication date: October 19, 2023
    Applicant: Bexion Pharmaceuticals Inc
    Inventors: Gilles Hughes Tapolsky, Ray Takigiku, Nilabh Chaudhary
  • Publication number: 20230226188
    Abstract: Disclosed are pharmaceutical compositions containing saposin C and phosphatidylserine that are useful for treating various cancers.
    Type: Application
    Filed: January 20, 2023
    Publication date: July 20, 2023
    Applicant: Bexion Pharmaceuticals Inc.
    Inventors: Ellen K. Monson, Xiaochen Wei, Ray Takigiku, Charles A. Cruze, III, Joseph W. Wyse
  • Publication number: 20220088042
    Abstract: Disclosed herein, according to the present invention, are methods of treating pancreatic cancer comprising administering a first pharmaceutical composition comprising Saposin C and dioleoylphosphatidylserine (SapC-DOPS) and administering a second pharmaceutical composition comprising an anti-neoplastic agent. Optionally, additional pharmaceutical compositions may be administered. Also disclosed are methods of inhibiting tumor growth. Also disclosed are kits for the treatment of pancreatic cancer comprising at least two pharmaceutical compositions, wherein a first pharmaceutical composition comprises SapC-DOPS and wherein a second pharmaceutical composition comprises a first antineoplastic agent.
    Type: Application
    Filed: May 24, 2021
    Publication date: March 24, 2022
    Inventors: Xiaoyang Qi, Olugbenga Olowokure, Ray Takigiku
  • Publication number: 20200384112
    Abstract: Disclosed are pharmaceutical compositions containing saposin C and phosphatidylserine that are useful for treating various cancers.
    Type: Application
    Filed: May 1, 2020
    Publication date: December 10, 2020
    Applicant: Bexion Pharmaceuticals Inc.
    Inventors: Ellen K. Monson, Xiaochen Wei, Ray Takigiku, Charles A. Cruze, III, Joseph W. Wyse
  • Publication number: 20200230128
    Abstract: Methods and compositions are provided which comprise effective amounts of an analgesic to treat a subject, including reducing or eliminating an adverse effect associated with the analgesic.
    Type: Application
    Filed: November 6, 2019
    Publication date: July 23, 2020
    Inventors: Paul Bosse, John AMELING, Bernard SCHACHTEL, Ray TAKIGIKU
  • Publication number: 20200206218
    Abstract: Methods and compositions are provided which comprise effective amounts of an analgesic to treat a subject, including reducing or eliminating an adverse effect associated with the analgesic.
    Type: Application
    Filed: October 30, 2019
    Publication date: July 2, 2020
    Inventors: Paul Bosse, John Ameling, Bernard Schachtel, Ray Takigiku
  • Patent number: 10682411
    Abstract: Disclosed are pharmaceutical compositions containing saposin C and phosphatidylserine that are useful for treating various cancers.
    Type: Grant
    Filed: November 2, 2018
    Date of Patent: June 16, 2020
    Assignee: Bexion Pharmaceuticals Inc.
    Inventors: Ellen K. Monson, Xiaochen Wei, Ray Takigiku, Charles A. Cruze, III, Joseph W. Wyse
  • Publication number: 20200129502
    Abstract: Methods and compositions are provided which comprise effective amounts of an analgesic to treat a subject, including reducing or eliminating an adverse effect associated with the analgesic.
    Type: Application
    Filed: July 3, 2019
    Publication date: April 30, 2020
    Inventors: Paul Bosse, John AMELING, Bernard SCHACHTEL, Ray TAKIGIKU
  • Patent number: 10532030
    Abstract: Methods and compositions are provided which comprise effective amounts of one or more analgesics, such as hydrocodone or acetaminophen, and an antiemetic, such as promethazine, to treat or prevent pain in a subject, and to reduce or prevent an adverse effect associated with the analgesics.
    Type: Grant
    Filed: May 30, 2018
    Date of Patent: January 14, 2020
    Assignee: LOCL PHARMA, INC.
    Inventors: Paul Bosse, John Ameling, Bernard Schachtel, Ray Takigiku
  • Publication number: 20190290764
    Abstract: Disclosed are pharmaceutical compositions containing saposin C and phosphatidylserine that are useful for treating various cancers.
    Type: Application
    Filed: November 2, 2018
    Publication date: September 26, 2019
    Applicant: Bexion Pharmaceuticals Inc.
    Inventors: Ellen K. Monson, Xiaochen Wei, Ray Takigiku, Charles A. Cruze, III, Joseph W. Wyse
  • Publication number: 20180344728
    Abstract: Methods and compositions are provided which comprise effective amounts of an analgesic to treat a subject, including reducing or eliminating an adverse effect associated with the analgesic.
    Type: Application
    Filed: July 17, 2018
    Publication date: December 6, 2018
    Inventors: Paul BOSSE, John AMELING, Bernard SCHACHTEL, Ray TAKIGIKU
  • Publication number: 20180333360
    Abstract: Methods and compositions are provided which comprise effective amounts of one or more analgesics, such as hydrocodone or acetaminophen, and an antiemetic, such as promethazine, to treat or prevent pain in a subject, and to reduce or prevent an adverse effect associated with the analgesics.
    Type: Application
    Filed: May 30, 2018
    Publication date: November 22, 2018
    Inventors: Paul BOSSE, John AMELING, Bernard SCHACHTEL, Ray TAKIGIKU
  • Publication number: 20180325892
    Abstract: Methods and compositions are provided which comprise effective amounts of an analgesic to treat a subject, including reducing or eliminating an adverse effect associated with the analgesic.
    Type: Application
    Filed: July 17, 2018
    Publication date: November 15, 2018
    Inventors: Paul BOSSE, John AMELING, Bernard SCHACHTEL, Ray TAKIGIKU
  • Patent number: 10064856
    Abstract: Methods and compositions are provided which comprise effective amounts of an analgesic to treat a subject, including reducing or eliminating an adverse effect associated with the analgesic.
    Type: Grant
    Filed: August 22, 2017
    Date of Patent: September 4, 2018
    Assignee: LOCAL PHARMA, INC.
    Inventors: Paul Bosse, John Ameling, Bernard Schachtel, Ray Takigiku
  • Patent number: 10016368
    Abstract: Methods and compositions are provided which comprise effective amounts of one or more analgesics, such as hydrocodone or acetaminophen, and an antiemetic, such as promethazine, to treat or prevent pain in a subject, and to reduce or prevent an adverse effect associated with the analgesics.
    Type: Grant
    Filed: November 8, 2016
    Date of Patent: July 10, 2018
    Assignee: LOCL PHARMA, INC.
    Inventors: Paul Bosse, John Ameling, Bernard Schachtel, Ray Takigiku
  • Publication number: 20180169120
    Abstract: Disclosed herein, according to the present invention, are methods of treating pancreatic cancer comprising administering a first pharmaceutical composition comprising Saposin C and dioleoylphosphatidylserine (SapC-DOPS) and administering a second pharmaceutical composition comprising an anti-neoplastic agent. Optionally, additional pharmaceutical compositions may be administered. Also disclosed are methods of inhibiting tumor growth. Also disclosed are kits for the treatment of pancreatic cancer comprising at least two pharmaceutical compositions, wherein a first pharmaceutical composition comprises SapC-DOPS and wherein a second pharmaceutical composition comprises a first antineoplastic agent.
    Type: Application
    Filed: November 21, 2017
    Publication date: June 21, 2018
    Inventors: Xiaoyang Qi, Olugbenga Olowokure, Ray Takigiku
  • Patent number: 9855264
    Abstract: Methods and compositions are provided which comprise effective amounts of an analgesic to treat a subject, including reducing or eliminating an adverse effect associated with the analgesic.
    Type: Grant
    Filed: September 12, 2016
    Date of Patent: January 2, 2018
    Assignee: LOCL PHARMA, INC.
    Inventors: Paul Bosse, John Ameling, Bernard Schachtel, Ray Takigiku
  • Publication number: 20170360772
    Abstract: Methods and compositions are provided which comprise effective amounts of an analgesic to treat a subject, including reducing or eliminating an adverse effect associated with the analgesic.
    Type: Application
    Filed: August 14, 2017
    Publication date: December 21, 2017
    Inventors: Paul BOSSE, John AMELING, Bernard SCHACHTEL, Ray TAKIGIKU
  • Publication number: 20170348305
    Abstract: Methods and compositions are provided which comprise effective amounts of an analgesic to treat a subject, including reducing or eliminating an adverse effect associated with the analgesic.
    Type: Application
    Filed: August 22, 2017
    Publication date: December 7, 2017
    Inventors: Paul BOSSE, John AMELING, Bernard SCHACHTEL, Ray TAKIGIKU
  • Publication number: 20170348303
    Abstract: Methods and compositions are provided which comprise effective amounts of an analgesic to treat a subject, including reducing or eliminating an adverse effect associated with the analgesic.
    Type: Application
    Filed: August 22, 2017
    Publication date: December 7, 2017
    Inventors: Paul BOSSE, John AMELING, Bernard SCHACHTEL, Ray TAKIGIKU